ESMO Clinical Practice Guidelines: Neuroendocrine Tumours
The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.
Latest enhanced and revised set of guidelines
ESMO has two Clinical Practice Guidelines on Neuroendocrine Tumours: Neuroendocrine bronchial and thymic tumours and Neuroendocrine gastroenteropancreatic tumours. They include information on incidence, diagnosis, staging and risk assessment, treatment, response evaluation and follow-up.
Neuroendocrine Bronchial and Thymic Tumours: ESMO Clinical Practice Guidelines
Published in 2012 – Ann Oncol 2012; 23 (Suppl 7): vii120-vii123.
Authors: K. Öberg, P. Hellman, P. Ferolla, M. Papotti
Neuroendocrine Gastroenteropancreatic Tumours: ESMO Clinical Practice Guidelines
Published in 2012 – Ann Oncol 2012; 23 (Suppl 7): vii124-vii130.
Authors: K. Öberg, U. Knigge, D. Kwekkeboom, A. Perren